Talk Presenting Companies (Theatre B) track
Technologies and Tools: KANTIFY
Tue, Nov 10, 2026 · 1:30–1:45 PM CET Koelnmesse
About this session
Kantify is a Belgium-based biotech using AI to discover new medicines against previously undruggable targets in oncology, CNS, and rare disease. Founded following a rare cancer diagnosis, the company was built on the conviction that patients with intractable diseases deserve access to molecules that conventional methods cannot reach. Kantify's platform, Sapian, is an AI-native, orthogonal approach to drug discovery. It integrates target identification with non-structure-based small molecule discvery- pioneering a method that operates independently of traditional screening infrastructures.
Speaker
-
CEO Kantify · KANTIFY
Speaker